Learn More
Bio X Cell Antibody, Human Amyloid-Beta, Lecanemab Biosimilar, 5 MG
Supplier: Bio X Cell SIM0032R005MG
This non-therapeutic biosimilar antibody utilizes Lecanemab's variable regions, suitable for research. It is a recombinant humanized IgG1 antibody targeting aggregated soluble and insoluble amyloid-beta (Aβ), implicated in Alzheimer's. It reduces Aβ plaques and prevents Aβ deposition with high selectivity for Aβ protofibrils.
- Non-therapeutic biosimilar antibody
- Recombinant humanized IgG1 antibody
- Targets aggregated soluble and insoluble amyloid-beta (Aβ)
- Reduces Aβ plaques; prevents Aβ deposition
- High selectivity to Aβ protofibrils
- Applications: Functional assays
- Clone: Lecanemab
- Isotype: Human IgG1, κ
- Immunogen: Human amyloid-beta
- Formulation: PBS, pH 7.0; no stabilizers/preservatives
- Purity: ≥95% by SDS-PAGE
- Molecular weight: 150 kDa
- Storage: 4°C; do not freeze.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.